Expression And Function Of Mir-92a In Ventricular Remodeling After Pci Treatment Of Acute Myocardial Infarction

Chaofeng Zhang,Weidang Wu,Congxia Wang,Xiaomin Zhou,Xiaohui Xu,Pengbo Geng,Jun Zhu

2017-01-01

Abstract:Percutaneous coronary intervention is the major approach treating acute myocardial infarction (AMI). However, PCI easily causes myocardial ischemia reperfusion injury (MIRI) leading to ventricular remodeling. MiR-92a is correlated with AMI pathogenesis. Its expression and function during ventricular remodeling in AMI patients after PCI treatment remain unclear. AMI patients after PCI surgery received ultrasonic cardiography (UCG) for measuring ejection fraction (EF), left ventricular end systolic diameter (LVESD), left ventricular thickness, left ventricular end diastolic diameter (LVEDD). Real-time PCR was used to measure miR-92a expression and its correlation with ventricular remodeling related indexes. Wild type (WT) and miR-29a KD rats were established for MIRI model. M type ultrasound was used to evaluate cardiac function, whilst ELISA was used to test contents of type I collagen, interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-alpha). Western Blot was used for detecting Bcl-2 protein expressions in myocardial cells. Patients after PCI had decreased EF, higher LVESD and LVEDD, lower left ventricular thickness, and enhanced miR-92a expression (P<0.05 compared to before surgery). MiR-92a was positively correlated with post-op EF and left ventricular thickness, and was negatively correlated with LVESD and LVEDD (P<0.05). MiR-92a KD MIRI rats had lower miR-92a expression, improved cardiac functions, lower type I collagen, higher Bcl-2, and decreased IL-6 and TNF-alpha expression (P<0.0 compared to WT). MiR-92a had elevated expression during ventricular remodeling. Inhibition of miR-92a could improve cardiac functions via suppressing type I collagen, decreasing apoptosis and inhibiting inflammation.